EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 103 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.90 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $2,000 | -90.5% | 300 | -78.3% | 0.00% | -100.0% |
| Q4 2019 | $21,000 | +40.0% | 1,380 | -8.7% | 0.00% | 0.0% |
| Q3 2019 | $15,000 | +650.0% | 1,512 | +950.0% | 0.00% | – |
| Q2 2019 | $2,000 | -88.9% | 144 | -89.1% | 0.00% | -100.0% |
| Q1 2019 | $18,000 | -88.8% | 1,323 | -91.6% | 0.00% | -90.9% |
| Q4 2018 | $160,000 | -53.9% | 15,779 | -45.5% | 0.01% | -45.0% |
| Q3 2018 | $347,000 | +984.4% | 28,954 | +898.4% | 0.02% | +566.7% |
| Q3 2017 | $32,000 | -43.9% | 2,900 | -59.7% | 0.00% | -40.0% |
| Q2 2017 | $57,000 | – | 7,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Simplify Asset Management Inc. | 2,700,000 | $823,500 | 0.09% |
| 683 Capital Management, LLC | 2,650,000 | $808,250 | 0.06% |
| GSA CAPITAL PARTNERS LLP | 355,867 | $109 | 0.01% |
| RBF Capital, LLC | 391,265 | $119,336 | 0.01% |
| UBS OCONNOR LLC | 393,975 | $120,162 | 0.00% |
| XTX Topco Ltd | 15,597 | $4,757 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 106,700 | $32,544 | 0.00% |
| AMERIPRISE FINANCIAL INC | 8,592,471 | $2,620,704 | 0.00% |
| DRW Securities, LLC | 120,365 | $37 | 0.00% |
| DFPG INVESTMENTS, LLC | 32,430 | $10,896 | 0.00% |